Literature DB >> 15709013

Human endogenous retrovirus HERV-K14 families: status, variants, evolution, and mobilization of other cellular sequences.

Aline Flockerzi1, Stefan Burkhardt, Werner Schempp, Eckart Meese, Jens Mayer.   

Abstract

The human genome harbors many distinct families of human endogenous retroviruses (HERVs) that stem from exogenous retroviruses that infected the germ line millions of years ago. Many HERV families remain to be investigated. We report in the present study the detailed characterization of the HERV-K14I and HERV-K14CI families as they are represented in the human genome. Most of the 68 HERV-K14I and 23 HERV-K14CI proviruses are severely mutated, frequently displaying uniform deletions of retroviral genes and long terminal repeats (LTRs). Both HERV families entered the germ line approximately 39 million years ago, as evidenced by homologous sequences in hominoids and Old World primates and calculation of evolutionary ages based on a molecular clock. Proviruses of both families were formed during a brief period. A majority of HERV-K14CI proviruses on the Y chromosome mimic a higher evolutionary age, showing that LTR-LTR divergence data can indicate false ages. Fully translatable consensus sequences encoding major retroviral proteins were generated. Most HERV-K14I loci lack an env gene and are structurally reminiscent of LTR retrotransposons. A minority of HERV-K14I variants display an env gene. HERV-K14I proviruses are associated with three distinct LTR families, while HERV-K14CI is associated with a single LTR family. Hybrid proviruses consisting of HERV-K14I and HERV-W sequences that appear to have produced provirus progeny in the genome were detected. Several HERV-K14I proviruses harbor TRPC6 mRNA portions, exemplifying mobilization of cellular transcripts by HERVs. Our analysis contributes essential information on two more HERV families and on the biology of HERV sequences in general.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709013      PMCID: PMC548434          DOI: 10.1128/JVI.79.5.2941-2949.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

2.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

3.  Repbase update: a database and an electronic journal of repetitive elements.

Authors:  J Jurka
Journal:  Trends Genet       Date:  2000-09       Impact factor: 11.639

Review 4.  Retroviruses and primate evolution.

Authors:  E D Sverdlov
Journal:  Bioessays       Date:  2000-02       Impact factor: 4.345

5.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Differences in HERV-K LTR insertions in orthologous loci of humans and great apes.

Authors:  Y B Lebedev; O S Belonovitch; N V Zybrova; P P Khil; S G Kurdyukov; T V Vinogradova; G Hunsmann; E D Sverdlov
Journal:  Gene       Date:  2000-04-18       Impact factor: 3.688

7.  Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W.

Authors:  Javier Costas
Journal:  Mol Biol Evol       Date:  2002-04       Impact factor: 16.240

Review 8.  Human endogenous retroviruses in the primate lineage and their influence on host genomes.

Authors:  J Mayer; E Meese
Journal:  Cytogenet Genome Res       Date:  2005       Impact factor: 1.636

9.  Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein.

Authors:  A Boese; M Sauter; U Galli; B Best; H Herbst; J Mayer; E Kremmer; K Roemer; N Mueller-Lantzsch
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

10.  Transduction of the human gene FAM8A1 by endogenous retrovirus during primate evolution.

Authors:  S Jamain; M Girondot; P Leroy; M Clergue; H Quach; M Fellous; T Bourgeron
Journal:  Genomics       Date:  2001-11       Impact factor: 5.736

View more
  14 in total

1.  A revised nomenclature for transcribed human endogenous retroviral loci.

Authors:  Jens Mayer; Jonas Blomberg; Ruth L Seal
Journal:  Mob DNA       Date:  2011-05-04

2.  Impact of endogenous intronic retroviruses on major histocompatibility complex class II diversity and stability.

Authors:  Gaby G M Doxiadis; Nanine de Groot; Ronald E Bontrop
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

3.  HERV-W group evolutionary history in non-human primates: characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini.

Authors:  Nicole Grandi; Marta Cadeddu; Jonas Blomberg; Jens Mayer; Enzo Tramontano
Journal:  BMC Evol Biol       Date:  2018-01-19       Impact factor: 3.260

4.  HERV-K(HML7) Integrations in the Human Genome: Comprehensive Characterization and Comparative Analysis in Non-Human Primates.

Authors:  Nicole Grandi; Maria Paola Pisano; Eleonora Pessiu; Sante Scognamiglio; Enzo Tramontano
Journal:  Biology (Basel)       Date:  2021-05-14

5.  Human endogenous retroviruses and cancer prevention: evidence and prospects.

Authors:  Luca Cegolon; Cristiano Salata; Elisabete Weiderpass; Paolo Vineis; Giorgio Palù; Giuseppe Mastrangelo
Journal:  BMC Cancer       Date:  2013-01-03       Impact factor: 4.430

6.  An Evolutionarily Young Polar Bear (Ursus maritimus) Endogenous Retrovirus Identified from Next Generation Sequence Data.

Authors:  Kyriakos Tsangaras; Jens Mayer; David E Alquezar-Planas; Alex D Greenwood
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

Review 7.  HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.

Authors:  Oliver Hohn; Kirsten Hanke; Norbert Bannert
Journal:  Front Oncol       Date:  2013-09-20       Impact factor: 6.244

8.  Human cytomegalovirus (HCMV) induces human endogenous retrovirus (HERV) transcription.

Authors:  Alice Assinger; Koon-Chu Yaiw; Ingmar Göttesdorfer; Christine Leib-Mösch; Cecilia Söderberg-Nauclér
Journal:  Retrovirology       Date:  2013-11-12       Impact factor: 4.602

Review 9.  High-Throughput Sequencing is a Crucial Tool to Investigate the Contribution of Human Endogenous Retroviruses (HERVs) to Human Biology and Development.

Authors:  Maria Paola Pisano; Nicole Grandi; Enzo Tramontano
Journal:  Viruses       Date:  2020-06-11       Impact factor: 5.048

10.  Degradation and remobilization of endogenous retroviruses by recombination during the earliest stages of a germ-line invasion.

Authors:  Ulrike Löber; Matthew Hobbs; Anisha Dayaram; Kyriakos Tsangaras; Kiersten Jones; David E Alquezar-Planas; Yasuko Ishida; Joanne Meers; Jens Mayer; Claudia Quedenau; Wei Chen; Rebecca N Johnson; Peter Timms; Paul R Young; Alfred L Roca; Alex D Greenwood
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.